Algernon Pharmaceuticals Inc (AGNPF)

[SO75]

Several mentions of significant time and needing more $$

2 million not gonna cut it.





to successfully commercialize products.
Successfully developing a breath test into a marketable device may take several years and significant
financial resources, and the Company may not achieve those objectIves


The Company will require equity and/or debt financing to support on-going operations

In the United States, the FDA regulates medical devices, including diagnostic tests, under the Federal
Food, Drug and Cosmetic Act. The FDA notification and approval process requires substantial time, effort
and financial resources,